Fig. 2From: Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonanceSummary of the effects of sodium-glucose cotransporter-2 inhibitors EPO: Erythropoietin. LV: left ventricular; RAAS: renin-angiotensin-aldosterone system;Back to article page